Paclitaxel Market in Vietnam - Manufacturing and Consumption, Outlook and Forecast 2020-2026

April 2020 | 106 pages | ID: P58FE47A1CB1EN
Market Monitor Global

Abstracts

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it 'taxol'.
This report contains market size and forecasts of Paclitaxel in Vietnam, including the following market information:
Vietnam Paclitaxel Market Revenue, 2015-2020, 2021-2026, ($ millions)
Vietnam Paclitaxel Market Consumption, 2015-2020, 2021-2026, (Kg)
Vietnam Paclitaxel Production Capacity, 2015-2020, 2021-2026, (Kg)
Top Five Competitors in Vietnam Paclitaxel Market 2019 (%)
The global Paclitaxel market was valued at 110.4 million in 2019 and is projected to reach US$ 152 million by 2026, at a CAGR of 8.3% during the forecast period. While the Paclitaxel market size in Vietnam was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Paclitaxel manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Paclitaxel production and consumption in Vietnam

Total Market by Segment:

Vietnam Paclitaxel Market, By Type, 2015-2020, 2021-2026 ($ millions) & (Kg)
Vietnam Paclitaxel Market Segment Percentages, By Type, 2019 (%)

• Natural Paclitaxel API
• Semi-synthetic Paclitaxel API

Vietnam Paclitaxel Market, By Application, 2015-2020, 2021-2026 ($ millions) & (Kg)
Vietnam Paclitaxel Market Segment Percentages, By Application, 2019 (%)

• Ovarian Cancer
• Cervical Cancer
• Breast Cancer
• Other

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Paclitaxel Market Competitors Revenues in Vietnam, by Players 2015-2020 (Estimated), ($ millions)
Total Paclitaxel Market Competitors Revenues Share in Vietnam, by Players 2019 (%)
Total Vietnam Paclitaxel Market Competitors Sales, by Players 2015-2020 (Estimated), (Kg)
Total Vietnam Paclitaxel Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:

• Phyton
• ScinoPharm
• Novasep
• Samyang
• Polymed
• TAPI (Teva)
• Fresenius-kabi
• Huiang biopharma
• Southpharma
• Yunnan Hande
• Hainan Yew Pharm

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Paclitaxel Market Definition
1.2 Market Segments
  1.2.1 Segment by Type
  1.2.2 Segment by Application
1.3 Vietnam Paclitaxel Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 COVID-19 IMPACT: VIETNAM PACLITAXEL OVERALL MARKET SIZE

2.1 Vietnam Paclitaxel Market Size: 2020 VS 2026
2.2 Vietnam Paclitaxel Revenue, Prospects & Forecasts: 2015-2026
2.3 Vietnam Paclitaxel Sales (Consumption): 2015-2026

3 COMPANY LANDSCAPE

3.1 Top Paclitaxel Players in Vietnam (including Foreign and Local Companies)
3.2 Top Vietnam Paclitaxel Companies Ranked by Revenue
3.3 Vietnam Paclitaxel Revenue by Companies (including Foreign and Local Companies)
3.4 Vietnam Paclitaxel Sales by Companies (including Foreign and Local Companies)
3.5 Vietnam Paclitaxel Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Paclitaxel Companies in Vietnam, by Revenue in 2019
3.7 Vietnam Manufacturers Paclitaxel Product Type
3.8 Tier 1, Tier 2 and Tier 3 Paclitaxel Players in Vietnam
  3.8.1 List of Vietnam Tier 1 Paclitaxel Companies
  3.8.2 List of Vietnam Tier 2 and Tier 3 Paclitaxel Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Vietnam Paclitaxel Market Size Markets, 2020 & 2026
  4.1.2 Natural Paclitaxel API
  4.1.3 Semi-synthetic Paclitaxel API
4.2 By Type - Vietnam Paclitaxel Revenue & Forecasts
  4.2.1 By Type - Vietnam Paclitaxel Revenue, 2015-2020
  4.2.2 By Type - Vietnam Paclitaxel Revenue, 2021-2026
  4.2.3 By Type - Vietnam Paclitaxel Revenue Market Share, 2015-2026
4.3 By Type - Vietnam Paclitaxel Sales & Forecasts
  4.3.1 By Type - Vietnam Paclitaxel Sales, 2015-2020
  4.3.2 By Type - Vietnam Paclitaxel Sales, 2021-2026
  4.3.3 By Type - Vietnam Paclitaxel Sales Market Share, 2015-2026
4.4 By Type - Vietnam Paclitaxel Price (Manufacturers Selling Prices), 2015-2026

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Vietnam Paclitaxel Market Size, 2020 & 2026
  5.1.2 Ovarian Cancer
  5.1.3 Cervical Cancer
  5.1.4 Breast Cancer
  5.1.5 Other
5.2 By Application - Vietnam Paclitaxel Revenue & Forecasts
  5.2.1 By Application - Vietnam Paclitaxel Revenue, 2015-2020
  5.2.2 By Application - Vietnam Paclitaxel Revenue, 2021-2026
  5.2.3 By Application - Vietnam Paclitaxel Revenue Market Share, 2015-2026
5.3 By Application - Vietnam Paclitaxel Sales & Forecasts
  5.3.1 By Application - Vietnam Paclitaxel Sales, 2015-2020
  5.3.2 By Application - Vietnam Paclitaxel Sales, 2021-2026
  5.3.3 By Application - Vietnam Paclitaxel Sales Market Share, 2015-2026
5.4 By Application - Vietnam Paclitaxel Price (Manufacturers Selling Prices), 2015-2026

6 MANUFACTURERS & BRANDS PROFILES

6.1 Phyton
  6.1.1 Phyton Corporate Summary
  6.1.2 Phyton Business Overview
  6.1.3 Phyton Paclitaxel Major Product Offerings
  6.1.4 Phyton Sales and Revenue in Vietnam (2015-2020)
  6.1.5 Phyton Key News
6.2 ScinoPharm
  6.2.1 ScinoPharm Corporate Summary
  6.2.2 ScinoPharm Business Overview
  6.2.3 ScinoPharm Paclitaxel Major Product Offerings
  6.2.4 ScinoPharm Sales and Revenue in Vietnam (2015-2020)
  6.2.5 ScinoPharm Key News
6.3 Novasep
  6.3.1 Novasep Corporate Summary
  6.3.2 Novasep Business Overview
  6.3.3 Novasep Paclitaxel Major Product Offerings
  6.3.4 Novasep Sales and Revenue in Vietnam (2015-2020)
  6.3.5 Novasep Key News
6.4 Samyang
  6.4.1 Samyang Corporate Summary
  6.4.2 Samyang Business Overview
  6.4.3 Samyang Paclitaxel Major Product Offerings
  6.4.4 Samyang Sales and Revenue in Vietnam (2015-2020)
  6.4.5 Samyang Key News
6.5 Polymed
  6.5.1 Polymed Corporate Summary
  6.5.2 Polymed Business Overview
  6.5.3 Polymed Paclitaxel Major Product Offerings
  6.5.4 Polymed Sales and Revenue in Vietnam (2015-2020)
  6.5.5 Polymed Key News
6.6 TAPI (Teva)
  6.6.1 TAPI (Teva) Corporate Summary
  6.6.2 TAPI (Teva) Business Overview
  6.6.3 TAPI (Teva) Paclitaxel Major Product Offerings
  6.6.4 TAPI (Teva) Sales and Revenue in Vietnam (2015-2020)
  6.6.5 TAPI (Teva) Key News
6.7 Fresenius-kabi
  6.6.1 Fresenius-kabi Corporate Summary
  6.6.2 Fresenius-kabi Business Overview
  6.6.3 Fresenius-kabi Paclitaxel Major Product Offerings
  6.4.4 Fresenius-kabi Sales and Revenue in Vietnam (2015-2020)
  6.7.5 Fresenius-kabi Key News
6.8 Huiang biopharma
  6.8.1 Huiang biopharma Corporate Summary
  6.8.2 Huiang biopharma Business Overview
  6.8.3 Huiang biopharma Paclitaxel Major Product Offerings
  6.8.4 Huiang biopharma Sales and Revenue in Vietnam (2015-2020)
  6.8.5 Huiang biopharma Key News
6.9 Southpharma
  6.9.1 Southpharma Corporate Summary
  6.9.2 Southpharma Business Overview
  6.9.3 Southpharma Paclitaxel Major Product Offerings
  6.9.4 Southpharma Sales and Revenue in Vietnam (2015-2020)
  6.9.5 Southpharma Key News
6.10 Yunnan Hande
  6.10.1 Yunnan Hande Corporate Summary
  6.10.2 Yunnan Hande Business Overview
  6.10.3 Yunnan Hande Paclitaxel Major Product Offerings
  6.10.4 Yunnan Hande Sales and Revenue in Vietnam (2015-2020)
  6.10.5 Yunnan Hande Key News
6.11 Hainan Yew Pharm
  6.11.1 Hainan Yew Pharm Corporate Summary
  6.11.2 Hainan Yew Pharm Paclitaxel Business Overview
  6.11.3 Hainan Yew Pharm Paclitaxel Major Product Offerings
  6.11.4 Hainan Yew Pharm Sales and Revenue in Vietnam (2015-2020)
  6.11.5 Hainan Yew Pharm Key News
6.12 Jiangsu Yew Biotechnology
  6.12.1 Jiangsu Yew Biotechnology Corporate Summary
  6.12.2 Jiangsu Yew Biotechnology Paclitaxel Business Overview
  6.12.3 Jiangsu Yew Biotechnology Paclitaxel Major Product Offerings
  6.12.4 Jiangsu Yew Biotechnology Sales and Revenue in Vietnam (2015-2020)
  6.12.5 Jiangsu Yew Biotechnology Key News

7 PACLITAXEL PRODUCTION CAPACITY, EXPORT AND IMPORT ANALYSIS

7.1 Paclitaxel Production Capacity and Value in Vietnam, Situation Analysis and Prediction, 2015-2026
  7.1.1 Vietnam Paclitaxel Production Capacity, 2015-2026
  7.1.2 Vietnam Paclitaxel Production 2015-2026
  7.1.3 Vietnam Paclitaxel Production Value 2015-2026
7.2 Key Local Paclitaxel Manufacturers in Vietnam
  7.2.1 Vietnam Key Local Paclitaxel Manufacturers Production Capacity
  7.2.2 Vietnam Key Local Paclitaxel Manufacturers Production
  7.2.3 Vietnam Key Local Paclitaxel Manufacturers Production Value
  7.2.4 The Proportion of Paclitaxel Production Sold in Vietnam and Sold Other Than Vietnam by Manufacturers
7.3 Paclitaxel Export and Import in Vietnam
  7.3.1 Vietnam Paclitaxel Export Market
  7.3.2 Vietnam Paclitaxel Source of Imports

8 COVID-19 IMPACT: KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

8.1 PESTLE Analysis for Vietnam Paclitaxel Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 IMPACT ON PACLITAXEL SUPPLY CHAIN ANALYSIS

9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
  9.4.1 Marketing Channels
  9.4.2 Paclitaxel Distributors and Sales Agents in Vietnam

10 CONCLUSION

11 APPENDIX

11.1 Note
11.2 Examples of Clients
11.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Key Players of Paclitaxel in Vietnam
Table 2. Top Players in Vietnam, Ranking by Revenue (2019)
Table 3. Vietnam Paclitaxel Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Vietnam Paclitaxel Revenue Share by Companies, 2015-2020
Table 5. Vietnam Paclitaxel Sales by Companies, (Kg), 2015-2020
Table 6. Vietnam Paclitaxel Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Paclitaxel Price (2015-2020) (USD/Kg)
Table 8. Vietnam Manufacturers Paclitaxel Product Type
Table 9. List of Vietnam Tier 1 Paclitaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Vietnam Tier 2 and Tier 3 Paclitaxel Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Paclitaxel Revenue in Vietnam (US$, Mn), 2015-2020
Table 12. By Type - Paclitaxel Revenue in Vietnam (US$, Mn), 2021-2026
Table 13. By Type - Paclitaxel Sales in Vietnam (Kg), 2015-2020
Table 14. By Type - Paclitaxel Sales in Vietnam (Kg), 2021-2026
Table 15. By Application - Paclitaxel Revenue in Vietnam, (US$, Mn), 2015-2020
Table 16. By Application - Paclitaxel Revenue in Vietnam, (US$, Mn), 2021-2026
Table 17. By Application - Paclitaxel Sales in Vietnam, (Kg), 2015-2020
Table 18. By Application - Paclitaxel Sales in Vietnam, (Kg), 2021-2026
Table 19. Phyton Corporate Summary
Table 20. Phyton Paclitaxel Product Offerings
Table 21. Phyton Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 22. ScinoPharm Corporate Summary
Table 23. ScinoPharm Paclitaxel Product Offerings
Table 24. ScinoPharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 25. Novasep Corporate Summary
Table 26. Novasep Paclitaxel Product Offerings
Table 27. Novasep Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 28. Samyang Corporate Summary
Table 29. Samyang Paclitaxel Product Offerings
Table 30. Samyang Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 31. Polymed Corporate Summary
Table 32. Polymed Paclitaxel Product Offerings
Table 33. Polymed Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 34. TAPI (Teva) Corporate Summary
Table 35. TAPI (Teva) Paclitaxel Product Offerings
Table 36. TAPI (Teva) Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 37. Fresenius-kabi Corporate Summary
Table 38. Fresenius-kabi Paclitaxel Product Offerings
Table 39. Fresenius-kabi Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 40. Huiang biopharma Corporate Summary
Table 41. Huiang biopharma Paclitaxel Product Offerings
Table 42. Huiang biopharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 43. Southpharma Corporate Summary
Table 44. Southpharma Paclitaxel Product Offerings
Table 45. Southpharma Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 46. Yunnan Hande Corporate Summary
Table 47. Yunnan Hande Paclitaxel Product Offerings
Table 48. Yunnan Hande Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 49. Hainan Yew Pharm Corporate Summary
Table 50. Hainan Yew Pharm Paclitaxel Product Offerings
Table 51. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 52. Jiangsu Yew Biotechnology Corporate Summary
Table 53. Jiangsu Yew Biotechnology Paclitaxel Product Offerings
Table 54. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue (US$, Mn) and Average Price (USD/Kg) (2015-2020)
Table 55. Paclitaxel Production Capacity (Kg) of Local Manufacturers in Vietnam, 2015-2020
Table 56. Paclitaxel Production (Kg) of Local Manufacturers in Vietnam, 2015-2020
Table 57. Vietnam Paclitaxel Production Market Share of Local Manufacturers, 2015-2020
Table 58. Paclitaxel Production Value (US$, Mn) of Local Manufacturers in Vietnam, 2015-2020
Table 59. Vietnam Paclitaxel Production Value Market Share of Local Manufacturers, 2015-2020
Table 60. The Percentage of Paclitaxel Production Sold in Vietnam and Sold Other Than Vietnam by Manufacturers
Table 61. The Percentage of Paclitaxel Production Sold in Vietnam and Sold Other Than Vietnam by Manufacturers
Table 62. Dangeguojia Paclitaxel Sales (Consumption), Production, Export and Import, 2015-2020
Table 63. Raw Materials and Suppliers
Table 64. Paclitaxel Downstream Clients in Vietnam
Table 65. Paclitaxel Distributors and Sales Agents in Vietnam

List Of Figures

LIST OF FIGURES

Figure 1. Paclitaxel Segment by Type
Figure 2. Paclitaxel Segment by Application
Figure 3. Dangeguojia Paclitaxel Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Paclitaxel Market Size in Vietnam, (US$, Mn) & (Kg): 2020 VS 2026
Figure 6. Vietnam Paclitaxel Revenue, 2015-2026 (US$, Mn)
Figure 7. Paclitaxel Sales in Vietnam: 2015-2026 (Kg)
Figure 8. The Top 3 and 5 Players Market Share by Paclitaxel Revenue in 2019
Figure 9. By Type - Vietnam Paclitaxel Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - Vietnam Paclitaxel Market Share, 2015-2020
Figure 11. By Type - Vietnam Paclitaxel Market Share, 2020-2026
Figure 12. By Type - Vietnam Paclitaxel Price (USD/Kg), 2015-2026
Figure 13. By Application - Paclitaxel Revenue in Vietnam (US$, Mn), 2020 & 2026
Figure 14. By Application - Vietnam Paclitaxel Market Share, 2015-2020
Figure 15. By Application - Vietnam Paclitaxel Market Share, 2020-2026
Figure 16. By Application -Vietnam Paclitaxel Price (USD/Kg), 2015-2026
Figure 17. Vietnam Paclitaxel Production Capacity (Kg), 2015-2026
Figure 18. Vietnam Paclitaxel Actual Output (Kg), 2015-2026
Figure 19. Vietnam Paclitaxel Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of Vietnam Paclitaxel Export Destination, 2019
Figure 21. The Source of Imports of Vietnam Paclitaxel, 2019
Figure 22. PEST Analysis for Vietnam Paclitaxel Market in 2020
Figure 23. Paclitaxel Market Opportunities & Trends in Vietnam
Figure 24. Paclitaxel Market Drivers in Vietnam
Figure 25. Paclitaxel Market Restraints in Vietnam
Figure 26. Paclitaxel Industry Value Chain